Chronic cutaneous wound infections and surgical site infections (SSIs) present a huge burden on the healthcare system and can lead to increased morbidity and mortality. Current diagnostic methods of identifying and confirming infection involve culture-based and molecular methods.
Chronic cutaneous wounds occur as a result of deficiencies in wound healing processes.
1,2 Chronic wounds have a major impact on patient's quality of life and present a huge burden on the healthcare system. 3, 4 Persistent cutaneous wound infection is a major contributor to delayed wound healing. 5, 6 Cutaneous infection following postsurgical intervention is also of clinical concern. Surgical site infections (SSIs) are common complications after surgery and can lead to increased morbidity and mortality. 7, 8 Common bacterial pathogens associated with chronic as well as superficial and deep SSIs include Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Pseudomonas aeruginosa, Streptococcus pyogenes, and Enterococcus faecalis. [9] [10] [11] [12] Current diagnostic methods of identifying and confirming cutaneous infections involve culture-based and molecular methods. Both techniques are time consuming, and culture-based methods have limited sensitivity and are susceptible to overestimation of skin commensals leading to incorrect causative bacterial identification. [13] [14] [15] Delays in diagnostics often result in the use of untargeted empirical treatment with a risk for suboptimal choice of antibiotics, the development of antibiotic resistance and increase in mortality. 16 An ideal diagnostic method would be noninvasive and highly sensitive and detect pathogenic organisms with a high degree of accuracy to allow targeted treatment.
Volatile organic compounds (VOCs) are a diverse group of carbon-based molecules, including alcohols, isocyanates, ketones, aldehydes, hydrocarbons, and sulfides, which are volatile at ambient temperatures. 17, 18 VOC sampling has the advantage of being painless, noninvasive, and reproducible. A compendium of VOCs emanating from the human body has been compiled with 1840 VOCs assigned from breath (872), saliva (359), blood (154) , milk (256), skin secretions (532), urine (279), and feces (381). 19 There is increasing evidence that VOCs or combinations of VOCs are unique to various disease states and their early detection could represent a useful means of diagnosis. VOCs have been identified as potential biomarkers in malignancies of the lung, 20 stomach, 21 head and neck, 22 breast, 23 liver, 24, 25 colon and prostate. 26 They have also been detected as markers of asthma, [27] [28] [29] chronic obstructive pulmonary disease, 30, 31 inflammatory bowel disease, 32, 33 and diabetes. 34, 35 Microorganisms produce and release VOCs and currently volatile detection via breath testing has been at the forefront in the potential of this technology to diagnose infection. 36 The ability to identify VOCs in cutaneous wound infections could lead to a noninvasive and time-efficient method of diagnosis.
The aim of this review is to provide a detailed update on VOCs produced and emitted by bacterial species commonly associated with cutaneous wound infections. It then describes the volatile profile of skin in health and disease. Finally, the role of volatile detection from cutaneous wounds is discussed. An extensive literature search was conducted on PubMed for relevant articles published from 1960 onwards. MeSH terms used included a variety of combinations including: SSI, surgical wound infection, VOCs, biofilm, staphylococcus, Escherichia coli, streptococcus, enterococcus, Pseudomonas aeruginosa, Grampositive bacteria, Gram-negative bacteria, wound infection, postoperative wound infection, wound healing, and skin.
CHRONIC WOUNDS AND SSIs
Chronic wounds represent a major burden on patients with the National Health Service expenditure in managing these wounds in excess of £1 billion annually. 3 Biofilms are present in more than half of chronic wounds and present a major obstacle in healing. 37 Over 50 million in-patient surgical procedures are performed in the USA annually with approximately 1-5% developing SSIs with a high associated mortality. 38, 39 SSIs pose a significant burden on the healthcare system leading to increase postoperative inpatient stay, increased expenses and readmissions. The preliminary management of SSIs involves preventative measures which include but are not limited to peri-operative antibiotics and meticulous skin preparation prior to the procedure. However, despite these measures SSIs represent the most common hospital acquired infections in surgical patients. 40 Risk factors associated with SSIs include patient and operative factors. Patient factors include diabetes, obesity, smoking, and preoperative active infection. [41] [42] [43] Operative factors include wound characteristics which can be classified into four categories, namely clean, cleancontaminated, contaminated, and dirty-infected. 44 An escalating risk of developing SSIs is linked to the level of wound characterization ranging from 1.3% for clean wounds to 40% for dirty-infected wounds. 45, 46 Other operative factors include preoperative showering and hair removal, hand washing and surgical attire, and intraoperative skin preparation. 47 Planktonic bacteria undergo a four phase cycle of growth consisting of a lag phase, log phase, stationary phase, and death phase. Biofilms are physiologically distinct from their planktonic counterparts and undergo a different developmental cycle, which involves initial attachment to the surface, irreversible attachment, maturation, and dispersion. 48 Biofilms are more prevalent than expected in surgical wounds with up to 80% of SSIs involving the presence of biofilm. 49 They are difficult to diagnose with culture methods proving obsolete in their detection. 50 Biofilms have been found on closure materials of healed surgical wounds 51 and on the surface of implanted surgical devices. 52 Biofilms are significantly more difficult to eradicate leading to a chronic inflammatory state which further negatively impacts wound healing 53 and persistence of infection. 54 Management of SSI associated biofilms requires invasive management involving surgical debridement of devitalized tissue, removal of infected devices and parenteral broad-spectrum antimicrobials. [55] [56] [57] This further highlights the need for rapid and accurate diagnostic tools to avoid a delay in optimum management.
SSIs are classified into three categories: superficial incisional where the infection occurs around the area of the skin where the incision was made; deep incisional where the infection occurs deep to the incision effecting the underlying fascia and muscle; and organ/space where the infection effects the organs or body cavities. 44 We propose the potential use of volatile detection as a means of diagnosing SSIs would be limited to superficial SSI and potentially deep SSI as these would allow the noninvasive capture of VOCs. The most typical causative microorganisms of superficial and deep SSIs are pathogens native to the patient's skin which include staphylococci, streptococci, enterococci, and Gram-negative bacilli.
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MICROORGANISMS AND VOCs
A portion of normal microbial metabolites produced are VOCs. 58 They are thought to evolve as products or byproducts of metabolic pathways. 59 Zoller and Clark were the first to report laboratory evidence of bacterial production of volatiles. 60 Many classification systems exist for microbial volatiles with one potential system categorizing them into fatty acid derivatives, aromatic compounds, nitrogen-containing compounds, sulfur compounds, terpenoids, halogenated selenium, tellurium, and other metalloid compounds. 61 Their production is dependent on the bacterial species, bacterial strains, bacterial growth phase, cocultures, pH, humidity, nutrients, temperature, and other environmental factors. 62, 63 The ability to rapidly sample and analyze VOCs, potentially allowing identification of bacteria, has massive implications in the management of infection in clinical settings.
VOC SAMPLING AND ANALYTICAL TECHNIQUES
There are numerous sampling techniques that have been utilized to collect and identify VOCs, the advantages and limitations of which are outlined in Figure 1 . These include VOC collection onto adsorbents, such as Tenax or solid-phase micro-extraction (SPME), 64 either directly or through an intermediary such as gauze or cotton pads 65 ; collection in sealed containers 66 ; direct or indirect solvent extraction 67 ; or combinations of the above. The above methods do not often identify all VOCs present due to selective adsorption of the trapping material and these sampling techniques limit accurate quantification of VOCs and therefore direct sampling are utilized. 68 There are a variety of analytical chemical techniques used in VOC detection (Figure 2 ). Gas chromatographymass spectrometry (GC-MS) is a combined analytical system and is one of the most widely used and powerful analytical chemical methods. It detects and quantifies VOCs over a range from parts per million to part per billion or less. Samples for GC-MS must be in the gaseous phase where they are injected into the chromatograph where an inert carrier gas transports it though a tubular column. The length of the columns used varies with longer columns providing better chromatographic resolution and maximum separation of analytes. Each compound is emitted from the column at different times with the mass spectrometer used to detect eluting compounds through compound ionization followed by measurement of the mass to charge ratio of each ion generating a unique mass spectrum for the compound. 69 The major advantages of GC-MS are increased sensitivity and compound identification is greatly facilitated by the availability of extensive and easily searchable databases. 70 However, it is not typically strong at identifying unknown compounds. Other limitations of GC-MS are increased processing and analysis times and similarity of molecular fragmentation patterns from structural isomers can make compound identification difficult. 71 Also, due to high detection limits, sample preconcentration using techniques described above are typically required, making quantification of VOCs very difficult. A time of flight (TOF) mass spectrometer serves a very similar purpose to GC-MS with the exception of providing a combination of high mass accuracy and extended range of detectable metabolites. 72 Ion mobility spectrometry (IMS) separates gas-phase ions based on their size and shape. 73 This technology has long been used in the detection of explosives and illegal substances. 74 It can be coupled to a preseparating multi capillary column (MCC) unit allowing two-dimensional volatile separation, significantly increasing the resolution of metabolites. 75 MCC allows minimization or avoidance of analyte interactions in the ionization region of the IMS, thus reducing the complexity of the measurement signal. 76 IMS is advantageous over GC-MS as ambient air can be used as the carrier gas, eliminating the need for a pure specialty inert gas or a vacuum. This has allowed IMS to be portable and provide on-site measurements. IMS is highly sensitive with very low detection limits between the parts per billion to parts per trillion ranges, offers excellent low detection limits and gives relatively rapid results. 77 IMS is however not suitable for identification of unknown compounds. Direct injection mass spectrometry methods include ion molecule reaction mass spectrometry (IMR-MS), secondary electrospray ionization mass spectrometry (SESI-MS), selected ion flow tube mass spectrometry (SIFT-MS) and proton transfer reaction mass spectrometry (PTR-MS). A drawback of conventional mass spectrometry instrumentation is the high fragmentation of molecules in a complex gas mixture secondary to high electron ionization leading to complex mass spectra with overlapping intensities, thus making quantification difficult or impossible. IMR-MS offers a very soft from of ionization leading to less fragmentation. SESI-MS utilizes electrospray ionization technique to produce analytes suitable for mass analysis. In PTR-MS, compounds are ionized via proton transfer prior to analysis. This involves the production of H 3 0 1 ions from high purity distilled water through a cathode ion source. SIFT-MS is similar to PTR-MS but is able to ionize a wider range of analytes as it uses a greater number of precursor ions (
2 ) for chemical ionization. 69 The major advantage of direct injection methods is quantification. These direct methods have also lower detection limits than GC-MS at parts per trillion ranges. They also provide real-time detection with no sample preparation or separation requirements. They are however limited in the range of VOCs detected compared to GC-MS and PTR-MS is limited to the identification of compounds with a higher proton affinity than water.
The electronic nose devices constitute a noninvasive technique capable of detecting and differentiating VOC patterns based on its ability to detect odor. The Cyranose 320 and E50835 electronic nose devices have been used in bacterial identification. These devices allow imprinting of an odor on its sensor chip micro-array which is composed of complex materials. When the sensors are exposed to a gas, the polymer absorbs the gas and swells, during which the distance between the conductive carbon particles increases and thus also increases the resistance of the sensor material. 78 This change in resistance is transmitted to a computer with the pattern of change in the sensor array being used to detect the gas. Electronic nose devices are powerful at differentiating between nonidentical samples, provide rapid results with on-site sampling. They are however limited due to temperature and humidity sensitivity, only detect patterns of VOCs programmed on their database and are not suitable for screening of unknown compounds.
VOCs PRODUCED BY MICROORGANISMS COMMONLY ASSOCIATED WITH WOUND INFECTION
This section details the VOCs identified from the common causative bacteria of wounds based on the different analytical techniques available. With regards to VOC quantities, based on analytical technique used studies varied with some presenting relative abundances whereas others identified absolute concentrations of compounds. The majority of studies have provided VOC abundances relative to other compounds identified. [79] [80] [81] [82] [83] [84] Studies where absolute abundances of VOCs are shown range from the parts per million volume to parts per trillion volume. [85] [86] [87] Parts per million volume concentrations equate to mg/L sampled, parts per billion volume concentrations equate to ng/L sampled and parts per trillion volume concentrations equate to pg/L sampled. Studies in which more than 5 VOCs were identified for a specific bacterial species, only the top 5 compounds based on abundance (either relative or absolute) are presented ( Table 1) . Studies where VOC production could not be attributed to an isolated bacterial species or strain were excluded.
Informatics approaches also varied between the studies evaluated. Four main methods were used to confirm identification of VOCs. Some studies compared mass spectra to reference libraries and databases, such as the National Institute of Standards and Technology (NIST), 83 91 Other studies compared mass spectra and peak retention times with those obtained from pure standard compounds. 82, 85, 92 The majority of studies combined the use of reference libraries and pure standard compounds for identification of VOCs. 79, 81, 86, 87, 89, [93] [94] [95] [96] [97] A third technique used was the manual comparison of mass spectra with those available in the literature. 94 Lastly, due to the limitations of certain analytical techniques in compound identification, concurrent techniques were utilized to confirm VOC identity.
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Neerincx et al. inoculated P. aeruginosa in brain heart infusion broth and sampled the headspace using Tenax TA at 16, 24, and 48 hours. 93 The top 5 VOCs emitted from P. aeruginosa cultures were methyl thiolacetate, 2,3-dimethyl-5-isopentylpyrazine, 2-methyl-3-(2-propenyl)-pyrazine, 3-methyl-1 H-pyrrole, and 6-tridecane. Sch€ oller et al. sampled volatile metabolites emitted from P. aeruginosa by diffusive sampling again using Tenax. 89 The major headspace VOC identified was dimethyl disulfide. Bean et al. were the first to report the application of twodimensional GC-TOF spectrometry to identify volatiles of P. aeruginosa grown for 24 hours in lysogeny broth in sealed GC headspace vials via SPME passive sampling. 88 This method facilitated the identification of 56 VOCs emitted by P. aeruginosa of which 28 were new including alcohols, heteroaromatics, ketones, benzenes, and aldehydes. 88 Scott-Thomas et al. used similar SPME sampling of the headspace of P. aeruginosa and found high concentrations of 2-aminoacetophenone. 84 Saranya et al. identified 2-[3-acetoxy-4,4,14-trimethylandrost-8-en-17-yl] propanoic acid was specific to Staphylococcus 80 and 3-methyl-1-butanol, 2-methylbutanal, 3-methyl-1-butanol, 3-methylbutanoic acid, and 2-methylbutanoic acid have been found to be significantly expressed in the headspace of S. epidermidis using the purge and trap technique. 79 Indole is produced by both pathogenic and nonpathogenic strains of E. coli cultured on a mixture of trypticase soy agar and brain heart infusion broth. 86 Bianchi et al. inoculated commercial tins of peeled tomatoes with E. coli and found the most abundant compounds detected were dimethylsulfide, 6-methyl-5-hepten-2-one, ethanol, ethyl acetate, and 3-methyl furan. 81 Umber et al. identified differing volatile signatures of E. coli dependant on the environment. Headspace analysis revealed E. coli inoculated whole blood released a different set of VOCs compared to E. coli cultured in Luria Bertani (LB) broth. 85 VOCs specific to E. coli-infected whole blood were dimethyl sulfide, carbon disulfide, ethanol, acetaldehyde, and methyl butanoate. Whereas dimethyl disulfide, dimethyl trisulfide, methyl propanoate, 1-propanol, and methylcyclohexane were isolated only from E. coli cultured in LB broth. 85 Filipiak et al. cultured S. aureus and P. aeruginosa in tryptic soy broth medium and collected headspace samples on multi-bed sorption tubes. 87 S. aureus released 32 VOCs and P. aeruginosa 37 of diverse chemical classes comprising aldehydes, alcohols, ketones, acids, sulfur containing compounds, esters, hydrocarbons, and nitrogen containing compounds. They found distinct differences in the bacteria-specific VOC profiles, especially with regard to aldehydes which were observed by S. aureus with no release observed from P. aeruginosa. 87 Preti et al. sampled the headspace of P. aeruginosa and S. aureus cultured in blood agar medium in Petri culture dishes and identified compounds specific to each species. 94 Zscheppank et al. utilized a novel needle trap technique consisting of a sorbent packed needle to sample headspace of E. coli and P. aeruginosa cultured in liquid media 102 and found both organisms produced isoprene. 82 Elgaali et al. utilized purge and trap and passive SPME sampling of the headspace to analyze E. coli and S. aureus. 95 Both sampling techniques identified indole as the principle component over the headspace of E. coli and the purge and trap technique identified long chain alcohols, 2-methylbutanol and 3-methylbutanol in abundance, whereas, passive SPME sampling of the headspace identified 2-tridecenone and dimethyldisulfide over the headspace of S. aureus. 95 Boots et al. sampled the bacterial headspace, using desorption tubes packed with carbograph 1TD/Carbopack X, of S. aureus, methicillin-resistant S. aureus (MRSA), P. aeruginosa, and E. coli cultured in a variety of agars and broths. 83 Samples were analyzed by GC-TOF-MS. They identified 25 VOCs which could be used to discriminate between the bacterial strains. They also found 1,1,2,2-tetrachloroethane, 2-heptanone and 1,4-dichlorobenzene are differentially excreted in the headspace of S. aureus and MRSA, with the latter two compounds significantly more abundant over the headspace of MRSA.
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Maddula et al. utilized MCC-IMS to identify ethanol,
heptan-2-one, and nonan-2-one emitted from the headspace of E. coli cultures. 76 Guam an et al. evaluated IMS and GC-MS in the detection of VOCs in the breath of rats injected intraperitoneally with E. coli or regular saline after 24 hours and found IMS had a higher sensitivity and specificity than GC-MS in distinguishing the two groups. 98 Kunze et al. analyzed using MCC-IMS the headspace of E. coli and P. aeruginosa cultured in Lysogeny Broth and found six VOCs (Decan-1-ol, Ethanol, Indole, Octan-1-ol [monomer and dimer], and P_755_105) exclusively over the headspace of E. coli cultures and 7 VOCs (2-Propanone, Azane [dimer], Dodecane, 2-Ethylhexan-1-ol, P_603_25, P_648_36, and P_778_4) emitted exclusively by P. aeruginosa cultures. 91 
Direct injection mass spectrometry
Only a single study to date has utilized IMR-MS to analyze the headspace over E. faecalis, S. aureus, and S. epidermidis cultured in blood agar and brain heart infusion broth. 92 They were able to differentiate between the species based on the mass spectra generated from the VOCs.
Zhu et al. were the first to report the application of SESI-MS to the detection and characterization of VOCs produced by P. aeruginosa, S. aureus, and E. coli cultured in tryptic soy broth. 90 They identified P. aeruginosa emitted ethanol and 4-Methylphenol in high abundance; S. aureus emitted high concentrations of butanol, acetone and acetic acid; E. coli principle emitted volatile was indole. A follow on study by the same group were able to distinguish 11 strains of E. coli from S. aureus based on VOCs. 103 In addition they identified 6 VOC biomarkers that were common in all E. coli strains.
Carroll et al. cultured different strains of P. aeruginosa on blood agar and pseudomonas-selective media and analyzed the headspace using SIFT-MS. 104 They identified the majority of strains emitted high quantities of ammonia and hydrogen cyanide compared to controls. Shestivska et al. corroborated the latter findings using both GC-MS and SIFT-MS. 96 They also identified a second compound, methyl thiocyanate, is commonly emitted from the majority of P. aeruginosa strains and most probably both compounds are biochemically associated. A follow on study by the same group identified differing production rates of VOC by genotypically different strains of P. aeruginosa, 97 which may allow differentiation between not only bacterial species but also strains of the same organism. Gilchrist et al. identified elevated concentrations of hydrogen cyanide in the breath of patients with chronic P. aeruginosa infections compared to controls. 105 However, it must be noted that the patients and controls may have been colonized by other bacteria. Allardyce et al. inoculated blood culture bottles, supplemented with tryptic soy broth, with isolated strains of P. aeruginosa, S. aureus, and E. coli and analyzed emitted VOCs using SIFT-MS at 6 hours. 106 Nine VOCs in total were assessed to differentiate between the bacterial strains. P. aeruginosa cultures had relatively high absolute concentrations of acetic acid and acetone; E. coli ethanol and acetaldehyde; and S. aureus ethanol and acetone. 106 Storer et al. used SIFT-MS to measure volatiles emitted from the headspace of urine samples inoculated with P. aeruginosa, S. aureus, S. epidermidis, E. coli, and E. faecalis at 6 hours. 107 The principle VOC emitted compared to noninoculated samples was formaldehyde for E. coli, ethanol for P. aeruginosa and ammonia for S. epidermidis, S. aureus, and E. faecalis. In contrast, Sovov a et al. found the principle volatile emitted from the headspace of E. coli cultured in nutrient broth enriched with glucose was ethanol. 108 This could be explained by the use of different media, strains, and growth conditions between the studies. This assumption is confirmed by Chippendale et al. who analyzed the VOC from the headspace of E. coli cultured in two different media. 109 E. coli cultured in Dulbecco's modified Eagle's medium resulted in large amounts of ethanol, acetaldehyde, and hydrogen sulfide production, whereas E. coli cultured in lysogeny broth, ammonia was the major volatile compound. 109 Lechner et al. used PTR-MS to analyze the headspace of E. coli, P. aeruginosa, and S. aureus cultured in either MacConkey agar or Mannitol-salt agar. 99 They identified patterns which were specific to the bacterial species however did not expand on the identity of the VOCs. Using PTR-MS, O'Hara, and Mayhew analyzed the headspace of S. aureus cultured in three different broths (nutrient, dextrose, and brain heart bovine) and found although the VOCs emitted were specific to S. aureus, their concentrations differed dependant on the type of media they were grown in. 100 Both Luchner et al. 101 and Bunge et al. 110 have utilized PTR-MS to identify volatiles in the headspace of E. coli.
Electronic nose
The Cyranose 320 and E50835 electronic nose devices have been utilized to differentiate between P. aeruginosa, S. aureus, and E. coli isolates based on VOC patterns from the headspace. 81, [111] [112] [113] However, it does not provide details regarding the individual volatile compounds emitted by the bacteria.
SKIN AND VOCs
Skin is the largest human organ 114 and forms an essential barrier between the body and the environment, protects
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from injury and provides vital homeostatic mechanisms including control of temperature, maintenance of fluid balance, and detection of sensations such as pain. 115 A compilation of 1840 VOCs emitted from healthy human individuals has recently been published with skin containing 532 different compounds. 19 The origins of VOCs emanating from skin are either from eccrine, sebaceous, and apocrine glandular secretions or metabolism of the skin microbiota 67, [116] [117] [118] [119] (Figure 3 ). VOCs released from skin are diverse including ketones, aldehydes, heterocyclic compounds, hydrocarbons, terpenes, esters, volatile sulfur compounds, and alcohols. 66, 67, [120] [121] [122] VOCs emitted from skin are affected by environmental factors such as diet and use of fragranced products such as soaps and perfumes. This makes study design difficult with studies to date varying on the protocol with regards to skin preparation prior to volatile extraction. Some have asked subjects to make no changes, 124 others have stipulated the avoidance of fragranced products, 67 while others have implemented dietary restrictions. 125, 126 Studies examining the skin volatilome have employed different sampling techniques. These include solvent extraction, dynamic headspace absorption indirectly or directly onto absorbent traps, trapping tubes allowing direct insertion into the GC and SPME. 68, 119, [127] [128] [129] [130] Each has their advantages and limitations including isolation of unexpected VOCs, exogenous contamination and loss of low molecular weight volatiles (Figure 1 ). 64 The top 5 VOCs identified from human skin are 6-methyl-5-hepten-2-one, nonanal, decanal, geranylacetone, and (E)-2-nonenal. 64 Harraca et al. analyzed the VOCs of the whole human body by collection through customized heat sealed oven bags which participants wore from the neck down and found the main compounds were heptanal, octanal, nonanal, decanal, 6-methyl-5-hepten-2-one, and geranylacetone. 126 The array of VOCs emitted from human skin also varies according to the body site sampled (Figure 4) . Axillary sampling has revealed high concentrations of alkanes, C6-C11 carboxylic acids, 3-methyl-2-hexenoic acid, and 3-hydroxy-3-methylhexanoic acid. 119, 127, 131 However, different sampling techniques have led to a different array of volatiles identified. 128 VOCs emitted from the hands often consist of aldehydes and ketones 64 and in addition forearm volatiles also comprise of alkanes and carboxylic acids. 67 The main volatiles released from feet are carboxylic acids. 132, 133 Ageing also seems to have an effect on VOC profiles of skin with four potential markers of aging namely (E)-2-nonenal, dimethylsulfone, benzothiazole, and nonanal identified. 67, 134 VOCs emitted from the skin have been studied as potential markers of disease. VOC patterns from skin melanoma have been identified using electronic nose devices 135 and Kwak et al. employed headspace SPME-GC-MS to identify specific volatiles that could differentiate between melanoma and normal melanocyte cells cultured in vitro. 136 They found melanoma cells emit dimethyl disulfide and dimethyl trisulfide along with higher concentrations of isoamyl alcohol compared to normal melanocytes. Abaffy et al. reported 3 studies utilizing headspace SPME-GC-MS for the differentiation of melanoma in vivo. [137] [138] [139] First, they identified 4-methyl decane, dodecane, and undecane were preferentially expressed in melanoma fresh and frozen tissue samples compared to control skin. 137 In a follow on case study they found 32 VOCs of which 23 were only detected from melanoma lesions compared to normal skin in the same individual. 138 They later followed this on with a pilot study in which they recruited 5 patients with melanoma and 5 patients with benign skin lesions and found increased levels of the fatty acids lauric acid and palmitic acid in melanoma. 139 The detection of VOCs from skin has also been applied experimentally to detect heart failure and diabetes. 140, 141 Voss et al. utilized an electronic nose device to detect emitted VOCs from skin and were able to discriminate between heart failure patients and controls with an accuracy of 87%. 140 Turner et al. used SIFT-MS to carry out a pilot study on five volunteers to determine VOC changes from skin before and after the ingestion of glucose in the fasting state. 141 VOCs were collected in a collection bag surrounding part of the arm and changes in acetone were noted post ingestion of glucose compared to the fasting state. 141 
WOUNDS, SSIs, AND VOCs
There are no studies published to date investigating the use of VOC detection in the diagnosis of SSIs. The evidence of VOCs emitted from cutaneous wounds is sparse with only two in vivo studies to date. Parry et al. utilized an electronic nose device which was able to differentiate between uninfected venous leg wounds and those infected with beta-hemolytic streptococci. 142 Thomas et al. obtained VOC samples from 5 patients with chronic lower limb wounds using a polydimethylsilicone membrane and analyzed by gas chromatography ion trap mass spectrometry. 143 They sampled from the wound, boundary areas around the wound and normal skin. They identified an array of VOCs which were unique to each of the sampled sites. They found significant differences in the VOC profile between normal skin and boundary skin and between normal skin and wounded skin but showed no difference between boundary skin and wound profiles. They recognized 6 compounds which may be responsible for this difference: 1-(1-methyethoxy) 2-propanol; dimethyl disulfide; 3-carene; 2-ethyl-1-hexanol; 3,5-bis(1,1-dimethylethyl)-phenol; and butylated hydroxytoluene. These compounds are often associated with preservatives found in creams and gels. However, they do elucidate that their protocol restricted the use of such creams and gels and that none of the patients reported using such products during the study period. Although study numbers were small, they provided a basis on which to develop further studies to identify the role of VOCs in wound healing. Dini et al. captured the volatiles emitted from compressed and noncompressed body regions using GC-MS and an electronic nose device. 144 Their main aim was to identify if the pattern of volatiles emitted differed dependant on skin pressure which would allow the potential identification of patients at risk of developing decubitus wounds. They found emissions from compressed tissue differed from those of noncompressed tissue allowing the potential to be able to noninvasively detect those at risk of developing wounds. 144 
CONCLUSIONS AND FUTURE PERSPECTIVES
VOCs emitted by microorganisms commonly associated with cutaneous wound infections are diverse. Studies isolating these pathogens have allowed the identification of potential combinations of volatiles which may allow detection of their presence. Although there are many VOCs that are shared between microorganisms, there are those identified to be unique to particular bacteria ( Table 2 ). This knowledge is imperative if VOC detection is to be developed not only to identify if a wound is infected or not but differentiate between causative microorganisms. Although it must be considered that the majority of studies have only investigated the VOC profile of a limited number of species and strains and this may not hold true when extrapolating this to significantly more species and strains.
Studies looking at the same organism have found different patterns of volatiles detected most probably explained by the use of different sampling methods and analytical techniques. Identifying and using the best suited sampling and analytical techniques will be critical. Although there is a wide spectrum of VOCs attributed to the presence of bacteria such as P. aeruginosa and E. coli, there is paucity in information available with regards to others such as MRSA, E. faecalis, and S. pyogenes. Also of note is that the methodology of the studies thus far employed the use of various media and broths which are not ideal models for skin and cutaneous wounds. Therefore, one must be wary of inferring which volatiles will be emitted by organisms in skin and wounds by extrapolating the findings from these studies. Also, the in vitro studies discussed above have all identified VOCs specific to bacterial species in the planktonic phase. Extrapolating this to the identification of the bio-burden in a biofilm state must be approached with caution as the presence of other biofilm components such as the extracellular polymeric substance may alter the VOC profile. Therefore, future studies must compare the VOC profiles of bacterial species in both their planktonic and biofilm states.
In vivo studies assessing VOCs released from skin have identified a vast array of volatiles in both health and disease with potential markers of cutaneous malignancy and other common diseases identified. However, studies again have varied with regards to sampling methods which have proved much more difficult compared to in vitro experimental sampling. Also, controlling for external factors have proven difficult in human subjects leading to identification of exogenous and contaminant VOCs despite robust attempts to minimize this. Information with regards to VOCs emitted from cutaneous wounds is very limited; however the couple of studies to date have provided a direction for future work.
Current laboratory-based techniques-culture and nonculture-based techniques-are time-consuming and culture overestimates rapidly dividing nonfastidious bacteria and underestimates more fastidious anaerobes. 50 Molecular methods provide a detailed breakdown of the polymicrobial nature of wounds, however, are deficient in providing information regarding the dominant strain or strains driving the infection. Therefore, the use of untargeted empirical antimicrobial treatment is common based on the limited strain information available, which causes delay in optimal wound management as well as risk for development of antimicrobial resistance. The addition of VOC profiling could provide a more detailed outlook on the development state of a biofilm and on the metabolic processes microorganisms are relying on to thrive in the wound, thus allowing treatment to be specifically tailored. With regards to utilizing VOC detection techniques in the diagnosis of chronic wound and SSIs, several limitations must be considered. As described above surgical patients undergo risk reducing measures such as peri-and postoperative antimicrobial administration and surgical skin preparation which will alter the wound microbiome. This in turn will alter the microbial metabolites produced and emitted from the wound surface. Also, the use of cosmetic and sanitary products which themselves will release VOCs have the potential to interfere and mislead. Other significant limitations are the spectrum of surgical wounds ranging from clean to dirty-infected and the phase of bacterial growth will provide a spectrum of microorganisms and therefore a substantially variable array of metabolites produced. Also most chronic wounds are poly-microbial in nature with the presence of different strains of the same species and the presence of more than one active microorganism will produce a different volatile signature compared to its isolated state. Therefore it is vital that any technique used has the capability to detect a multitude of VOCs and the ability to identify poly-microbial infections to aid specificity in diagnoses of SSIs.
There are currently no approved tests based on VOC detection in the diagnosis of SSI or cutaneous wound infections. However, there are FDA approved devices available in the diagnosis of asthma, 145 Helicobacter pylori infection 146 and heart transplant rejection, 147 which are all based on VOC detection. There is currently a huge interest and a developing body of work in the use of VOC detection in the diagnosis and monitoring of various diseases ranging from infection to malignancy. 148, 149 Volatile detection via breath testing has been at the forefront in the potential of this concept to diagnose infection. It is controversial whether an organism can be identified by its VOC profile as these are influenced by environmental factors, co-cultures, and species strains. 62 However, recent studies on mono-and co-cultures of species in different growth conditions associated with infections in cystic fibrosis patients have yielded patterns of VOCs that allowed species identification. 93, 150, 151 Also, Kunze et al. found no difference between VOC patterns of different strains of a single species and concluded that VOC patterns of a bacterial strain can be transferred to other strains of the same species. 91 VOCs also provide information about hostinfection interactions and the types of metabolic processes occurring. 120, 152 Rather than just species identification, VOC profiling could be used to delineate the stage of infection based on the activation of certain metabolic processes, 153 thus not only allowing identification of infection but allowing the tailoring of treatment of chronic wounds and monitoring treatment response.
We propose the need for further in vitro experimental work and robust clinical studies to identify signature volatiles of the common organisms attributed to the etiology of chronic wounds and SSIs. Culturing these bacteria on skin explants and combining these with substrates such as Matrigel 154 to allow representation of cutaneous wounds in vitro would allow a more accurate determination of VOCs produced and emitted. Taking this information with volatiles emitted from acute, chronic, and surgical wounds in vivo would potentially allow identification of VOCs which could be attributed to infected wounds and normal and abnormal wound healing. The ultimate goal would be to develop a clinical diagnostic tool which is inexpensive, portable, noninvasive, and reliable and offers time-efficient results in detecting cutaneous wound infections to expedite accurate management. VOC detection has the potential to offer this.
